did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780198515890

Reducing the Burden of Headache

by ; ;
  • ISBN13:

    9780198515890

  • ISBN10:

    0198515898

  • Format: Hardcover
  • Copyright: 2003-05-15
  • Publisher: Oxford University Press
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $261.33

Summary

This is the first book devoted to the study of the social and economic consequences of headache. Reducing the Public Burden of Headache analyses the financial cost of headache diseases, the disability and suffering they cause and the impact they have on the quality of life and the sufferers and their families. These are issues of major importance; migraine appears in the top 20 list of diseases ranked according to years lived with the disability. Headache, in general, is thought to account for approximately 20% of all days lost from work. Of even greater importance is the impact on everyday life, syudies have shown that migraine has a greater impact on the quality of life of sufferers than many other diseases generally considered to be more serious. This book describes and analyses the epidemiological data accumulated in the field and suggests guidelines and interventions aimed at improving healthcare for headache. Adoption of these suggestions combined with judicious use of existing resources and modern treatment options can lead to great improvements in the lives of headache sufferers world-wide. This book will be of interest to neurologists, general practitioners, epidemiologists, public health specialists, health service managers and all those interested in improving services and outcomes for sufferers of headache.

Table of Contents

List of contributors
xii
Section I Headache-related disability
1(96)
Overview of headache prevalence, burden, and management
3(12)
Richard B. Lipton
Ann I. Scher
Walter F. Stewart
Measuring headache disability
15(12)
Ann I. Scher
Richard B. Lipton
Walter F. Stewart
Benefits of treatment on headache disability---a personal view on selected data
27(15)
Carl G.H. Dahlof
Comparing disability and psychological factors in migraine and transformed migraine
42(4)
J.E. Magnusson
W.J. Becker
Cognitive efficiency following migraine therapy
46(6)
Kathleen Farmer
Roger K. Cady
Dennis Reeves
Joseph Bleiberg
Comparative evolution of MIDAS score after monotherapy with triptans
52(5)
S. Harmousi-Peioglou
A. Dimitriadis
G. Vlachogianni
Disability-adjusted life years (DALYs) and MIDAS in Japan
57(5)
F. Sakai
H. Igarashi
M. Iigaya
Disability in German headache sufferers: evaluation of a German headache disability inventory
62(5)
Stefan Evers
Birg Bauer
Ingrid Gralow
Ingo W. Husstedt
MIDAS as a tool for monitoring the benefits of treatment strategies over time
67(5)
S. Chauvet
E.A. MacGregor
The MIDAS questionnaire in children and young adolescents with headache: a pilot study
72(3)
L. Grazzi
D. D'Amico
F. Andrasik
S. Usai
M. Leone
A. Rigamonti
G. Bussone
Relationship between disability and quality of life in migraine
75(4)
D. D'Amico
S. Usai
A. Solari
L. Grazzi
M. Leone
A. Rigamonti
G. Bussone
Migraine in France in 2000: epidemiological data
79(8)
P. Henry
J.P. Auray
G. Duru
G. Chazot
J.F. Dartigues
M. Lanteri-Minet
C. Lucas
A. Pradalier
A. El Hasnaoui
A.F. Gaudin
Validation of the Headache Impact Test™ using patient-reported symptoms and headache severity
87(6)
J.B. Bjorner
J.E. Ware Jr
M. Kosinski
M. Diamond
S. Tepper
A. Dowson
M.S. Bayliss
A.S. Batenhorst
Headache-related disability: discussion summary
93(4)
T.J. Steiner
Section II Patient-centred measures: health-related quality of life
97(58)
Measuring health-related quality of life: general principles
99(8)
Patrick Henry
Virginie Chrysostome
Philippe Michel
Jean Francois Dartigues
Effect of headache on quality of life
107(9)
G.M. Terwindt
M.D. Ferrari
L.J. Launer
Assessment of the responsiveness of the Migraine-Specific Quality of Life Questionnaire (version 2.1)
116(5)
Bradley C. Martin
Dev S. Pathak
W. Jackie Kwong
Alice S. Batenhorst
Marc Sharfman
Comparison of the impact of eletriptan versus sumatriptan on migraine-specific quality of life
121(5)
Paula A. Funk-Orsini
Robert Miceli
Joan Mackell
Nicholas E.J. Wells
Impact of cluster headache on health-related quality of life
126(3)
D. D'Amico
A. Rigamonti
A. Solari
M. Leone
S. Usai
L. Grazzi
G. Bussone
Improvement in migraine-specific quality of life with eletriptan (Relpax™) as compared to Cafergot®
129(5)
Paula A. Funk-Orsini
Robert Miceli
Joan Mackell
Nicholas E.J. Wells
Improvements in health-related quality of life with long-term use of sumatriptan therapy for migraine
134(6)
T.A. Burke
W. Jackie Kwong
Alice S. Batenhorst
Psychometric evaluation of a computerized program to assess migraine-specific quality of life in clinical practice
140(4)
Lisa K. Mannix
W. Jackie Kwong
Elizabeth P. Skinner
Todd A. Dimsdale
Quality of life and disability in transformed migraine with drug overuse
144(4)
D. D'Amico
L. Grazzi
S. Usai
A. Solari
M. Leone
A. Rigamonti
G. Bussone
Quality of life and migraine: a multicentre Spanish study
148(5)
M.J.A. Lainez
R. Leira
J. Pascual
E. Diez Tejedor
F. Morales
F. Titus
R. Alberca
Patient-centred measures: health-related quality of life: discussion summary
153(2)
Hartmut Gobel
Section III Family burden, comorbidities, and health-care utilization
155(54)
Family impact of migraine
157(7)
Robert Smith
Lora A. Hasse
Migraine comorbidity with stroke, epilepsy, and major depression
164(9)
Naomi Breslau
Health-care utilization for headache
173(6)
Birthe Krogh Rasmussen
Functional improvement in migraine patients treated with oral eletriptan versus sumatriptan: a pooled analysis
179(6)
Volker Limmroth
Jayasena Hettiarachchi
Health-care utilization for in-patient headache therapy
185(4)
Hartmut Gobel
Peter Buschmann
Axel Heinze
Self-described `sinus headache' and headache-related impact
189(5)
Curtis P. Schreiber
Roger K. Cady
Reducing the personal burden of migraine: a patient's perspective
194(3)
Anne Bulow-Olsen
The burden of migraine in a sample of doctors of an Italian general hospital in Rome
197(5)
T. Catarci
F. Baldinetti
F. Granella
The Framig 2000 (II) survey: therapeutical data
202(3)
C. Lucas
M. Lanteri-Minet
C. Chaffaut
The Framig 2000 (III) survey: health-care use
205(2)
C. Lucas
M. Lanteri-Minet
C. Chaffaut
Family burden, comorbidities, and health care utilization: discussion summary
207(2)
Richard B. Lipton
Section IV Economics of headache
209(70)
General principles of disease-costing
211(7)
Bengt Jonsson
The economic burden of headache
218(5)
Jean Francois Dartigues
Philippe Michel
Patrick Henry
Measuring the economic benefits of pharmacotherapy---general principles
223(9)
Nicholas E.J. Wells
The economic cost and benefit of pharmacotherapy for headache
232(12)
Michael T. Halpern
A stratified approach to migraine management including zolmitriptan is clinically and economically superior to step care approaches: results from the Disability in Strategies of Care (DISC) study
244(6)
B. Charlesworth
Richard B. Lipton
WalteF. Stewart
A comparative study of the effectiveness of eletriptan, Cafergot®, and sumatriptan in reducing the time loss associated with migraine attacks
250(5)
Nicholas E.J. Wells
The socio-economic impact of migraine in Spain
255(5)
M.J.A. Lainez
M.J. Monzon
Reductions in medical and pharmacy resource utilization associated with the addition of preventive medication to the migraine management strategy
260(4)
Stephen D. Silberstein
Paul K. Winner
Joseph J. Chmiel
Utilization and price differentials of selective 5-HT1-receptor agonists in the European countries
264(7)
Pietro Folino-Gallo
Fabio Palazzo
Giuseppe Stirparo
Sergio De Filippis
Paolo Martelletti
Regaining time lost during migraine attacks with eletriptan
271(5)
Nicholas E.J. Wells
Economics of headache: discussion summary
276(3)
Jes Olesen
Section V Guidelines and interventions
279(66)
Evidence-based guidelines for migraine headache
281(9)
Stephen D. Silberstein
Model interventions to improve headache outcomes in health-care systems
290(12)
Morris Maizels
Model interventions to improve headache outcomes in the workplace
302(11)
Walter F. Stewart
Richard B. Lipton
Analysis of headache patients' behaviour in the pharmacy: results of a French multicentre study
313(5)
Bruno Mihout
Michel Lanteri-Minet
Alain Slama
Fatima Nachit-Ouinekh
Comparison of the efficacy of self-medication and medical prescriptions in reducing the burden of headache
318(6)
Hartmut Gobel
Marianne Petersen-Braun
Axel Heinze
Evaluation of migraine in the workplace
324(4)
S. Finkelstein
E. Berndt
G. Pransky
J. Mackell
Headache patient management in 21 Italian headache centres
328(5)
Paola Torelli
Gian Camillo Manzoni
Migraine and chronic idiopathic headache in the French workforce: detection and management. The NOEMIE study protocol
333(5)
Fatima Nachit-Ouinekh
Mohamed El Amrani
Abdelkader El Hasnaoui
HIT-6™ scores discriminate among headache sufferers differing in headache-associated workplace productivity loss
338(5)
M.S. Bayliss
M. Kosinski
M. Diamond
S. Tepper
W.H. Garber
J.E. Ware Jr
A.S. Batenhorst
Guidelines and interventions: discussion summary
343(2)
Hans-Christoph Diener
Section VI Improving health-care systems for headache
345(66)
Integrating headache services across the primary/secondary-care interface
347(14)
T.J. Steiner
Comprehensive academic headache centres
361(9)
Hartmut Gobel
Headache clinic or pain centre: together or separate
370(3)
Hans-Christoph Diener
The first year of the Lariboisiere emergency headache centre: a series of 10510 patients
373(3)
D. Valade
A. Ducros
M. El Amrani
L. Ben Slamia
C. Roos
R. Djomby
V. Domigo
L. Morin
V. Besancon
M.G. Bousser
Headache symptoms and other headache features in non-specified headaches in primary care
376(3)
R. Smith
L.A. Hasse
P.N. Richey
A.E. Cassedy
D.J. Rudawsky
Headache treatment outcome: a proposed paradigm for quantitative analysis
379(7)
M.C. Borrell-Wilson
C. Cahill-Wright
Development of HIT-6™, a paper-based short form for measuring headache impact
386(5)
M.S. Bayliss
J.B. Bjorner
M. Kosinski
C.G.H. Dahlof
A. Dowson
R.K. Cady
J.E. Ware Jr
A.S. Batenhorst
Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway
391(4)
Lars Jacob Stovner
Knut Hagen
Lars Vatten
John-Anker Zwart
Steinar Krokstad
Gunnar Bovim
Reducing the burden of headache by communicating treatment strategies for employees
395(7)
Hartmut Gobel
Peter Buschmann
Axel Heinze
Elke Puffel
Joachim Kruger
Frank Meyer
Bertold Nicola
Frederico Polano
The usefulness of the publication, Patient-centered strategies for effective management of migraine, in primary care
402(6)
Roger K. Cady
Kathleen Farmer
Curtis P. Schreiber
Robert Kaniecki
Improving health-care systems for headache: discussion summary
408(3)
Stephen D. Silberstein
Index 411

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program